Multi-strain synbiotic and lifestyle modifications on patients with metabolic dysfunction-associated steatotic liver disease (MASLD): a randomized double-blinded placebo-controlled trial
Supplementation with multi-strain synbiotics, in combination with lifestyle modifications, could serve as a promising adjunctive therapy to control disease progression in patients with MASLD.
Authors
- Ali Reza Riazi (ORCID: https://orcid.org/0000-0002-2200-7997)
- Amirreza Jabbaripour Sarmadian (ORCID: https://orcid.org/0000-0001-7677-8458)
- Zeinab Nikniaz (ORCID: https://orcid.org/0000-0001-6522-1048)
- Masood Faghih Dinevari (ORCID: https://orcid.org/0000-0001-6349-9708)
- Tahereh Vaezi
- Samaneh Abbasian
- Tayyebeh Vaezi
Institutions
- Tabriz University of Medical Sciences (IR)
Publication Details
- Journal
- European journal of medical research
- Published
- 2026-01-30
- DOI
- https://doi.org/10.1186/s40001-026-03901-3
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00